Hepatology / ILBS Addl Prof Dr Ashok Choudhury Features Among World’s Top 2% Scientists In Gastroenterology And Hepatology
·1 hour ago·2 min read
Key Points
Dr Ashok Choudhury, Additional Professor of Hepatology and Liver Transplantation at ILBS New Delhi, has featured in the Stanford-Elsevier World's Top 2% Scientists List in Gastroenterology and Hepatology.
New Delhi, Oct 9: Dr Ashok Choudhury, Additional Professor of Hepatology and Liver Transplantation at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, has featured in the Stanford–Elsevier World’s Top 2% Scientists List in Gastroenterology and Hepatology.
Released on October 7, 2026, the list identifies influential researchers across scientific disciplines based on citation data and other indicators of research impact. This year, it featured 2,253 researchers globally and 43 from India in gastroenterology and hepatology.
Dr Choudhury’s academic record includes more than 167 peer-reviewed publications, 9,564 citations and an h-index of 36.
A clinician-scientist specialising in liver failure, liver cancer, liver transplantation and artificial intelligence in hepatology, Dr Choudhury has contributed to the development of the AARC-ACLF Score. His work also includes the concepts of the Golden Window for sepsis management and the Transplant Window in acute-on-chronic liver failure, which address critical treatment decisions for patients with severe liver disease.
Released on October 7, 2026, the list identifies influential researchers across scientific disciplines based on citation data and other indicators of research impact. This year, it featured 2,253 researchers globally and 43 from India in gastroenterology and hepatology.
Dr Choudhury’s academic record includes more than 167 peer-reviewed publications, 9,564 citations and an h-index of 36.
A clinician-scientist specialising in liver failure, liver cancer, liver transplantation and artificial intelligence in hepatology, Dr Choudhury has contributed to the development of the AARC-ACLF Score. His work also includes the concepts of the Golden Window for sepsis management and the Transplant Window in acute-on-chronic liver failure, which address critical treatment decisions for patients with severe liver disease.
📱 Get Argus News App
✨📰 60 Word News🎬 Argus Podcast📺 Live TV and Breaking News🔔 Free Notification Alerts
Download Free:
International Research Collaborations
Dr Choudhury has participated in pan-Asian collaborative research registries focused on acute-on-chronic liver failure (ACLF). He has also been involved in research on disparities in cirrhosis care and outcomes, connecting 127 centres across 46 countries.
His recognitions include the Asia Pacific Rising Star Award in 2024 from the Asian Pacific Association for the Study of the Liver (APASL), along with young investigator honours from international liver societies and a research award from the American Association for the Study of Liver Diseases (AASLD).
Alongside his research, Dr Choudhury treats complex liver diseases and mentors DM and PhD scholars. His work also spans clinical and translational research, medical technology and artificial intelligence-based innovations in liver care.
Research And Public Health Awareness
Dr Choudhury has delivered more than 150 invited lectures across nearly 20 countries. His presentations have included engagements at Stanford University, the Massachusetts Institute of Technology and Johns Hopkins University, as well as major international liver society meetings.
Beyond clinical practice and research, he promotes preventive healthcare through the Know Hepatitis–No Hepatitis school-awareness campaign and LiFe (Living Initiative with Fresh Energy), which encourage healthier lifestyles in schools, institutions and communities.
His inclusion in the Stanford–Elsevier list highlights the international reach of his research and his contribution to collaborative efforts to improve liver care.
Dr Choudhury has participated in pan-Asian collaborative research registries focused on acute-on-chronic liver failure (ACLF). He has also been involved in research on disparities in cirrhosis care and outcomes, connecting 127 centres across 46 countries.
His recognitions include the Asia Pacific Rising Star Award in 2024 from the Asian Pacific Association for the Study of the Liver (APASL), along with young investigator honours from international liver societies and a research award from the American Association for the Study of Liver Diseases (AASLD).
Alongside his research, Dr Choudhury treats complex liver diseases and mentors DM and PhD scholars. His work also spans clinical and translational research, medical technology and artificial intelligence-based innovations in liver care.
Research And Public Health Awareness
Dr Choudhury has delivered more than 150 invited lectures across nearly 20 countries. His presentations have included engagements at Stanford University, the Massachusetts Institute of Technology and Johns Hopkins University, as well as major international liver society meetings.
Beyond clinical practice and research, he promotes preventive healthcare through the Know Hepatitis–No Hepatitis school-awareness campaign and LiFe (Living Initiative with Fresh Energy), which encourage healthier lifestyles in schools, institutions and communities.
His inclusion in the Stanford–Elsevier list highlights the international reach of his research and his contribution to collaborative efforts to improve liver care.
Related Topics
Explore more stories